Results from another study indicated that LECT2 is a crucial role in liver tumorigenesis as its absence alters the tumor phenotype and the tumor microenvironment suggested that LECT2 is a promising immunotherapeutic option for HCC (29). Here, LECT2 is linked to neoplasm.